Recent Company News

• 04:38 AM ET Oct 01, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:53 AM ET Nov 06, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (86 total)

• 02:11 AM ET Nov 06, 2025
  

  Hikma Pharmaceuticals Plc November Trading Statement: tightens FY25 core operating profit range to $730M to $750M (1771.0000p, 0)

• 02:02 AM ET Nov 06, 2025
  

  Hikma Pharmaceuticals announces the launch of STARJEMZA (ustekinumab-hmny) injection (1771.0000p, 0)

• 01:43 PM ET Oct 17, 2025
  

  UK closes in on drug pricing deal with White House - FT

• 05:11 AM ET Oct 06, 2025
  

  Celltrion presents positive real-world data on the use of subcutaneous infliximab at MTE Sessions at UEG 2025 (KRW 175400.0000, 0)

• 02:25 AM ET Sep 29, 2025
  

  Hikma Pharmaceuticals and Gedeon Richter receive FDA approval for denosumab biosimilars Enoby and Xtrenbo (1644.0000p, 0)

• 12:50 PM ET Sep 26, 2025
  

  White House says the latest pharmaceutical tariffs do not apply to countries with negotiated trade deals -- wires